Poly-DL-Lactic-co-Glycolic Acid

Also known as: Poly dl lactic co glycolic acid , 50:50; 12000 mw

Poly lactic-co-glycolic acid (PLGA) is biocompatible & biodegradable polymer which is used to fabricate devices for drug delivery & tissue engineering applications.

List of Excipients

Full Screen View

Reset Filter

Price Info

Nomisma Healthcare

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

PLGA-PEG

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications: PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral

Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US

Upload
your Marketing & Sales content

Nomisma Healthcare

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

PLGA

PDF Supplier PDF

URL Supplier Web Content

LM Application #LearnMore

Applications: PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Ingredient(s): Poly DL Lactide co Glycolide

Dosage Form: Injectable / Parenteral, Tablet

Category: Controlled & Modified Release, Parenteral

Route of Administration (Grade): Oral, Parenteral

Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

ASK
US

Upload
your Marketing & Sales content